Â鶹¹û¶³´«Ã½

Corporate Information

Company Name Â鶹¹û¶³´«Ã½ Co., Ltd.
Date Established December 6, 1941
Head Office 4-6-10 Koishikawa, Bunkyo-ku, Tokyo 112-8088, Japan
Telephone 81-3-3817-3700
Representatives Haruo Naito, Representative Corporate Officer and CEO
Yasushi Okada, Representative Corporate Officer
Keisuke Naito, Representative Corporate Officer and Executive Vice President
Capital 44,986 million Yen (as of March 31, 2024)
Scope of Business Research and development, manufacture, sale and import and export of pharmaceuticals
Organization Chart
Employees Consolidated : 11,067
Non-Consolidated : 2,984 (as of March 31, 2024)
Production Plants Kawashima Industrial Park (Gifu Prefecture)
Kashima Plant (Ibaraki Prefecture)
Â鶹¹û¶³´«Ã½ Manufacturing Ltd. (U.K.)
Â鶹¹û¶³´«Ã½ China Inc. Suzhou Plant (China)
Â鶹¹û¶³´«Ã½ (Liaoning) Pharmaceutical Co., Ltd. Benxi Plant (China)
Â鶹¹û¶³´«Ã½ Pharmaceuticals India Pvt. Ltd. (India), etc.
Laboratories Tsukuba Research Laboratories (Ibaraki Prefecture)
Kawashima Industrial Park (Gifu Prefecture)
Kashima Business Office (Ibaraki Prefecture)
Kobe Research Laboratories (Hyogo Prefecture)
Â鶹¹û¶³´«Ã½ Center for Genetics Guided Dementia Discovery (G2D2) (U.S.A.)
Exton Site (U.S.A.)
Hatfield Research Institute (U.K.), etc.
Overseas Sales Offices Â鶹¹û¶³´«Ã½ Inc. (U.S.A.)
Â鶹¹û¶³´«Ã½ Ltd. (U.K.)
Â鶹¹û¶³´«Ã½ GmbH (Germany)
Â鶹¹û¶³´«Ã½ S.A.S. (France)
Â鶹¹û¶³´«Ã½ China Inc. (China)
Â鶹¹û¶³´«Ã½ Korea Inc. (South Korea), etc.

Stock Information

Fiscal Year End March 31
Record Date for Dividend Year-end dividend - March 31
Interim dividend - September 30
Annual Shareholders' Meeting June
Stock Exchange Listings Tokyo Stock Exchange
Stock Trading Unit 100 shares
Ticker Code 4523